Bioprocessing Application Notes & Case Studies

  1. Fab Antibody Fragment Titer Improvement 2/2/2026

    Learn how systematic screening of unique expression strains and plasmid combinations can overcome low protein yields, achieving active Fab titers over 4 g/L.

  2. Advancing An Integrated Biopharma Workflow Strategy 1/30/2026

    Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.

  3. Enhancing Novel Developability Through Automated MS Analytics 1/29/2026

    Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.

  4. Transforming Development Through Mass Spectrometry Data Analysis 1/29/2026

    Mass spectrometry is vital for understanding PTMs in modern biologics. Explore key challenges and how streamlined analysis can reveal deeper, more sensitive insights into biotherapeutic structure.

  5. End-To-End Workflow Integration For Antibody Development 1/29/2026

    Modern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.

  6. Automating Mass Spectrometry Analysis To Accelerate Oligonucleotide Drug Development 1/29/2026

    Oligonucleotide therapeutics demand precise and efficient analytical workflows. Explore how automated data processing offers a faster path to understanding metabolites and advancing development.

  7. Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation 1/29/2026

    Growing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.

  8. Handling Demanding Active Ingredients Safely And Efficiently 1/27/2026

    See three flexible Optima fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.

  9. Manufacturing of "MSC 2.0" Using Functionally Closed Systems 1/27/2026

    Transitioning to closed systems enables the 100-fold expansion of engineered cells. Achieve high yields and maintain anti-cancer potency while reducing contamination risks and labor.

  10. Spatial Organization Of The CAR Is Critical For CAR T Cell Function 1/27/2026

    Explore how advanced single‑cell analysis links CAR localization, cell structure, and functional behavior, offering deeper insight into CAR T cell heterogeneity and performance.